This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chronos Therapeutics Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Luca Raveglia
Introduction
Luca Raveglia is a notable inventor based in Verona, Italy. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target orexin receptors. His work is crucial in addressing various health issues, including substance dependence and cognitive disorders.
Latest Patents
Luca Raveglia holds a patent for "Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonists." This patent describes a compound that is useful as an antagonist of the orexin-1 and orexin-2 receptors. The compounds are designed to be effective in the treatment or prevention of conditions such as anxiety disorders, panic disorders, binge eating, and Alzheimer's disease.
Career Highlights
Raveglia is associated with Chronos Therapeutics Limited, where he applies his expertise in drug development. His innovative approach has led to advancements in therapeutic options for various mental health and cognitive disorders.
Collaborations
Luca collaborates with talented professionals in his field, including Fabrizio Micheli and Barbara Bertani. Their combined efforts contribute to the ongoing research and development of effective treatments.
Conclusion
Luca Raveglia's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions are paving the way for new treatments that can significantly improve the quality of life for individuals facing challenging health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile